Embed Size (px)
Citation preview
Harvard Medical School Massachusetts General Hospital
CURRICULUM VITAE
Date Prepared: May 15,2017
Name: Christopher Putnam Stowell
Education 6/1971 A.B.
(with Honors) Biology Brown University
2/1978 Ph.D. Biochemistry Y.C. Lee, Ph.D.
The Johns Hopkins University
6/1982 M.D. Medicine University of Connecticut
P td t IT ..OS oc ora rammg 3/78-8/79 Postdoctoral Fellow Biochemistry
Y.C. Lee, Ph.D. The Johns Hopkins University
7/82-6/84 Resident Clinical Pathology Hospital of the University of Pennsylvania
7/84-6/85 Chief Resident Clinical Pathology Hospital of the University of Pennsylvania
7/85-6/86 Fellow Transfusion Medicine Hospital ofthe University of Pennsylvania
Faculty Academic Appointments 7/86-6/91 Assistant Clinical
Professor Pathology Vanderbilt University School of
Medicine 6/91-7/01 Instructor Pathology Harvard Medical School 8/01-3110 Assistant Professor Pathology Harvard Medical School 4/10 Associate Professor Pathology Harvard Medical School
A . t t tHOSpl•ta1/Affir t dl ft f.ppom mens a 1 Ia e ns I u wns 7/86-6/88 Associate Staff Pathology St. Thomas Hospital 7/86-6/91 Visiting Staff Pathology Vanderbilt University Medical
Center 7/88-6/91 Active Staff Pathology St. Thomas Hospital 7/91-7/99 Assistant Pathologist Pathology Massachusetts General Hospital 7/91 Consultant Pathology Bums Institute, Shriners Hospital for
Crippled Children 8/99-8/13 Associate Pathologist Pathology Massachusetts General Hospital 8/13 Pathologist Pathology Massachusetts General Hospital
2
Other Professional Positions 1988-1991 Acting Medical Director Blood Services, American Red Cross,
Tennessee Valley Region
Major Administrative Leadership Positions Local 1986-1991 1987-1991 1989-1991 19911991-1997
1997
1993-2002
1997-2007
2002
2007
Medical Director, Blood Bank Medical Director, Critical Care Laboratory Chief, Clinical Pathology Director, Blood Transfusion Service Medical Director, IV Team and Intraoperative Blood Recovery and Reinfusion Team Consultant, IV Team and Intraoperative Blood Recovery and Reinfusion Team Director, Transfusion Medicine Fellowship Program Associate Director for Recruiting, Pathology Residency Training Program Associate Director, Harvard Medical School Fellowship Program in Transfusion Medicine
Associate Director for Clinical Pathology,
Partners Hematology Oncology Fellowship Program
St. Thomas Hospital St. Thomas Hospital St. Thomas Hospital Massachusetts General Hospital Massachusetts General Hospital
Massachusetts General Hospital
Massachusetts General Hospital
Massachusetts General Hospital
Massachusetts General Hospital Harvard Medical School
Massachusetts General Hospital
National
1997 Program Director, Blood Substitutes American Association of Blood Banks
1998 Program Director, Preoperative Autologous Blood Donation
American Association of Blood Banks
1999 Program Director, Autologous Transfusion Practices
American Association of Blood Banks
1999 Program Director, Hemoglobin-based Blood Substitutes
American Association of Blood Banks
2003 2004
Program Director, Emerging Technologies in Transfusion Medicine
American Association of Blood Banks
2003 Program Director, From Physiology to Transfusion: New Insights into Oxygen Delivery and Platelet Function
American Association of Blood Banks
2003 Program Director, Emerging Technologies in Transfusion Medicine
American Association of Blood Banks
3
2010 Program Director, Red Blood Cell Transfusion and the Microcirculation
American Association of Blood Banks
2010 Program Director, Red Blood Cell Storage and Clinical Outcomes: The State of the Controversy
American Association of Blood Banks
2011 Program Director, The Biology and Clinical Effects of RBC Storage
XIII International Symposium on Blood Substitutes and Oxygen Therapeutics
Committee Service Local 1986-1988 Patient Care Monitoring Committee St. Thomas Hospital 1986-1991 Medical Advisory Committee American Red Cross, Tennessee Valley Region
Ad Hoc Budget Advisory 1987 American Red Cross, Tennessee Valley Region
Committee Ad Hoc Computer System
1987 American Red Cross, Tennessee Valley Region Evaluation Committee
1987-1991 Institutional Review Board St. Thomas Hospital 1987-1991 Utilization Review Committee St. Thomas Hospital 1987-1991 Critical Care Committee St. Thomas Hospital 1988-1991 Pharmacy and Therapeutic Agents St. Thomas Hospital
Committee 1990-1991 Library Committee St. Thomas Hospital 1988-1991 Blood Services Committee American Red Cross, Tennessee Valley Region 1988 Ad Hoc Quality Assurance American Red Cross, Tt Valley
Committee Region 1991 Tissue Services Committee American Red Cross, Tennessee Valley Region 1991 Transfusion Committee Massachusetts General Hospital
1991-1999 Chair 1991-1994 AIDS Committee Massachusetts General Hospital 1991-1994 Informed Consent Committee Massachusetts General Hospital 1991-1997 Resident Recruiting Committee Department of Pathology
Massachusetts General Hospital 1994-1997 Chair
1992-1994 Bone Marrow Transplant Operations Massachusetts General Hospital Committee
1993 Infusion Unit Implementation Team Massachusetts General Hospital 1995-1997 Partners Blood Bank Team Massachusetts General Hospital 1995-1997 Operations Improvement Blood Bank, GI Bleeding, Vascular Surgery,
Committees Massachusetts General Hospital 1996-2001 Executive Committee Department of Pathology
Massachusetts General Hospital 1997 Resident Training Program Department of Pathology
Committee Massachusetts General Hospital
2000-2002 Fellowship Program in Transfusion Harvard Medical School
4
Medicine Committee 2000-2002 Co-Chair
2001-2005 Bone Bank Advisory Committee Massachusetts General Hospital 2005-2013 Tissue Banking Committee Massachusetts General Hospital
2005-2013 Chair 2007 Pathology Training Program
Executive Committee Department of Pathology Massachusetts General Hospital
2011-2014 Professional Compensation Committee
Department ofPathology Massachusetts General Hospital
2012 Clinical Research Workgroup, Continuous Research Operations Improvement
Massachusetts General Hospital
2013 Diversity Committee Department of Pathology Massachusetts General Hospital
Regional American Red Cross, Tennessee Valley Region I 1986-1999 I Medical Advisory Committee American Red Cross, Northeast Region I 1991-1999 I Medical Advisory Committee
National 2009, 2012
External Review Committee
2015
Division of Transfusion Medicine, Magnusson Clinical Center, National Institutes ofHealth
Chair 2014 Study Section: RF A HL-14-004
Ancillary Studies in Clinical Trials National Heart, Lung and Blood Institute, National Institutes of Health
2016 External Scientific Review Committee
Food and Drug Administration, Center for Biologics Evaluation and Research, Laboratory of Plasma Derivatives
2017 Food and Drug Administration Science Review Board - Ad hoc external expert
Food and Drug Administration, Center for Biologics Evaluation and Research
Professional Societies 1976 Society for Complex Carbohydrates 1986 American Association of Blood
Banks 1988-1990 Member, Southeast District Advisory Group 1989-1993 Member, Membership Committee 1990-1996 Inspector 1991-1994 Member, Standards Committee 1993-1999 Member, Scientific Section Coordinating Committee 1997-1999 Vice Chair, Scientific Section Coordinating
5
Committee 1995-1999 Chair, Autologous Transfusion Committee 1997-2000 Chair, Ad Hoc Blood Substitutes Committee 1998-1999 Member, Transfusion Practices Program Committee 1998-1999 Member, Nominating Committee 1998 Abstract Reviewer 2002-2006 Member, Board of Directors 2004-2006 Member, Marketing Committee 2004-2006 Member, Publications Committee 2011-2015 Member, Annual Meeting Planning Program Unit
1986 Tennessee Association of Blood Banks 1987-1989 Director, Central Tennessee 1987-1990 Annual Meeting Planning Committee 1989-1990 Secretary 1990-1991 Coordinator of Education
1987 College of American Pathologists 1987-1991 Inspector
1991 Massachusetts Association of Blood Banks
2008 Academy of Clinical Laboratory Physicians and Scientists 2015-2016 Nominating C:ommittee 2016 Executive Board
2009 Association of Pathology Chairs Program Directors Section 2009-2014
2010-2014 Laboratory Management Education Task Force
Chair 2010 Curriculum Committee - Outcomes and Assessment
2009-2010 National Heart, Lung, and Blood Institute State-of-the Science Symposium: Transfusion Medicine
Transfusion in Surgery Committee
Editorial Activities 1995 Ad hoc reviewer New England Journal ofMedicine, Transfusion,
Journal ofClinical Apheresis, Vox Sanguinis 2010 Guest Editor Transfusion and Apheresis Science
Honors and Prizes: 1971 A.B. with Honors in Biology Brown University Academic 1971 Summer Student Fellowship Brookhaven National Laboratory Academic 1972-1978 NIH Predoctoral Fellowship The Johns Hopkins University Academic 1978 Sigma Xi The Johns Hopkins University Academic 2001 Partners in Excellence A ward Massachusetts General Hospital Service
6
9/11 Blood Bank Team 2001 Lemuel Diggs Award Tennessee Association of Blood
Banks Service and Education
2002 DeGowin Lectureship University of Iowa Medical School
Academic and Education
2006 C.M. Asuncion Lectureship St. Francis Hospital, University of Connecticut School of Medicine
Academic and Education
2007 Partners in Excellence A ward ARC Contract Team
Massachusetts General Hospital Service
2007 Morten Grove-Rasmussen Award Massachusetts Association of Blood Banks
Service and Education
2008 Partners in Excellence A ward HCLL Implementation Team
Massachusetts General Hospital Service
2008 Partners in Excellence A ward Individual A ward
Massachusetts General Hospital Service
2002 2003 2005 2008 2010-16
Best Clinical Pathology Rotation of the Year (Blood Bank)
Massachusetts General Hospital Education
2013 Partners in Excellence A ward Blood Transfusion Service Marathon Bombing
Massachusetts General Hospital Service
PastFund'mg 1992-1994 A Double-blind, Placebo-controlled Study to Determine Whether Pro-crit (EPOIETIN
ALF A) Can Reduce Peri-operative Transfusion Requirements in Patients Undergoing Major Orthopedic Surgery. R.W. Johnson Pharmaceutical Research Institute; M92-011; Phase III drug trial Site PI The major goals of the study were to determine if baseline hemoglobin concentration correlated with RBC transfusion, and if peri-operative administration of erythropoietin before orthopedic surgery could reduce allogeneic RBC transfusion. My role as the MGH site PI was to fulfill requirements for IRB approval and reporting, consent research subjects, evaluate adverse events, and supervise the study coordinator.
1993-1994 A Pilot Phase Ib Study to Evaluate the Safety and Tolerance of Hemoglobin-Based Oxygen Carrier-201 (HBOC-201) in Patients Undergoing Open Repair of a Unilateral Long Bone Fracture, Hip Replacement or Knee Replacement. Biopure, Inc.; M9990-0068; Phase Ib drug trial Site PI This was a safety study performed in a population of patients undergoing orthopedic surgery. My role as the MGH site PI was to fulfill requirements for IRB approval and reporting, consent research subjects, evaluate adverse events, and supervise the study
7
/ coordinator.
1994-1995 An Open-Label, Randomized, Parallel Group Study to Compare the Safety and Efficacy of Two Dosing Regimens of Pro-crit (EPOIETIN ALF A) in Subjects Undergoing Major Orthopedic Surgery. R.W. Johnson Pharmaceutical Research Institute; N93-057; Phase III drug trial Site PI The objective of this study was to compare the change in pre-operative hemoglobin levels in patients receiving two different dosing regimens of erythropoietin as well as their use of transfused allogeneic RBC. My role as the MGH site PI was to fulfill requirements for IRB approval and reporting, consent research subjects, evaluate adverse events, and supervise the study coordinator.
1996-1997 An Open-Label, Randomized, Parallel Group Study to Compare the Safety and Efficacy of Pro-crit (EPOIETIN ALF A) Administered Perioperatively and Autologous Predeposit to Reduce the Risk of Allogeneic Transfusion in Subjects Undergoing Major Orthopedic Surgery R.W. Johnson Pharmaceutical Research Institute; EPO-AP02-474; Phase III drug trial Site PI This study compared allogeneic RBC transfusion rates between patients undergoing total joint arthroplasty who were randomized to receive peri-operative erythropoietin, or to donate autologous RBC prior to surgery. My role as the MGH site PI was to fulfill
study.
1999-2002 The Effect of Procrit on Hemoglobin and Hematocrit and the Relationship to Postoperative Function, Vigor and Strength in Patients undergoing Primary, Total Joint Arthroplasty: A Randomized, Parallel Group, Open-Label Trial. R.W. Johnson Pharmaceutical Research Institute; PR98-024; Phase IV drug trial Site Co-PI This study assessed post-operative function among patients who had undergone major joint replacement who were randomized to to receive peri-operative erythropoietin, or to donate autologous RBC prior to surgery. My role as the MGH site PI was to fulfill requirements for IRB approval and reporting, consent research subjects, evaluate adverse events, and supervise the study coordinator.
2000-2001 A Prospective, Randomized, Concurrent Trial of Leukoreduction for all Hospitalized Patients. Baxter HealthCare Corporation; investigator-initiated individual research project Co-PI The object of the study was to determine if there were differences in significant clinical outcomes (death, length of stay, infection rate) among patients who received leukoreduced blood components compared to patients receiving conventional, non-leukoreduced blood components. I participated in all phases of the study including design, execution, data
8
Ianalysis and writing.
1998-2004 An Open-label, Randomized, Parallel Group Study to Confirm the Safety and Efficacy of Procrit (EPOIETIN ALF A) Administered Perioperatively vs. Standard of Care in Blood Conservation in Subjects Undergoing Major Elective Spinal Surgery R.W. Johnson Pharmaceutical Research Institute; PR97-19-002; Phase IV drug trial Site PI The study was carried out to determine if the incidence of thrombotic complications was increased m spme surgery patients, who do not routinely receive prophylactic anticoagulation, receiving peri-operative erythropoietin. My role as the MGH site PI was to fulfill requirements for IRB approval and reporting, consent research subjects, evaluate adverse events, and supervise the study coordinator. In addition to MGH being the top enrolling site, I was also on the writing committee.
2005-2006 Noninvasive Transdermal Delivery of Topical Anesthetics Using Ultrasound Pretreatment of Skin for Donors in a Blood Center Sontra Medical Corporation; 2004-TA-05; investigator-initiated individual research project Site PI The objective of this study was to evaluate the safety and efficacy of ultrasonicallyfacilitated delivery of an approved topical anesthetic. As the PI, I was responsible for the
2005-2006 Measurement of Soluble CD44 in Autologous Stem Cell Grafts. MGH Department of Pathology Vickery Grant; investigator-initiated research study Co-PI The goal of the study was to determine if there was a correlation between expression of CD44 in peripheral blood stem cell graft material in patients with hematologic malignancies and clinical outcomes following autologous transplantation. I was responsible for the IRB approvals and reporting, and participated directly in the study design and data analysis, as well as writing the paper.
2007-2014 Red Cell Storage Duration Study (RECESS) National Heart, Lung and Blood Institute Site PI; Vice-Chair, Protocol Leadership Committee This multi-center study, which is being performed by the NHLBI-supported Transfusion Medicine/Hemostasis Clinical Trials Network, will compare clinical outcomes in cardiac surgery patients randomized to receive RBC stored for :::; 10 d or :=::: 20 d. The results were published in 2015 (Ref. 35) and 2017 (Ref. 46).
2009-2014 Impact of Duration of Storage of Blood on Physiologic Variables in Cardiac Surgical Subjects Enrolled in the RECESS Trial (RECAP) National Heart, Lung and Blood Institute; 1 R01 HL101382-0l Co-PI
9
Tissue oxygen saturation and microcirculatory flow will be assessed using non-invasive techniques among patients enrolled in the parent RECESS study at 4 sites including MGH to compare these physiologic measures among cardiac surgery patients receiving RBC stored for < 10 d or > 20 d. The results were published in 2017 (Ref. 45).
2012-2015 Tissue Oxygenation by Transfusion in Anemia with Lactic Acidosis National Heart, Lung and Blood Institute; 1 R21 HL109518-01A1 Investigator This funding is for a prospective, randomized clinical trial comparing clinical outcomes and lactate levels in children in Uganda with severe malarial anemia who will be transfused with conventional banked RBC which have been stored for .:::; 10 d vs. units which have been stored for::::::. 25 d up to the allowed maximum ( 42 d). The protocol follows the design of a pilot study conducted in 2011-12 which demonstrated that lactic acidosis was corrected by RBC transfusion. The results were published in 2015 and 2016 (Refs. 39, 40, 42).
Report of Local Teaching and Training
Teaching of Students in Courses Other than Harvard University of Pennsylvania School of Medicine 1982-1986 Pathology Taught Section/Lab
25-2na year medical students 2 h contact/wk, 4 h preparation/wk for 8 weeks
Vanderbilt University School of Medicine 1986-1991 Introduction to Clinical Medicine Transfusion Medicine Lecture
100-2°0 year medical students 1 h lecture/yr, 2-4 h preparation/yr
Transfusion Medicine Section/Lab
12-2nd year medical students 4 h contact/yr, 2-4 h preparation/yr
1986-1991 Vanderbilt-Me harry Combined Lecture Pro gram
Blood Banking and Coagulation Lectures
20 medical technology undergraduates
6 h contact/yr, 6 h preparation/yr
Teach'mg ofStudentsm. Courses at Harvard 1991-1994 Pathophysiology 200 Transfusion Medicine Section/Lab
8-2°0 year medical students 2 h contact/yr, 4 h preparation/yr.
1991-1995 Internal Medicine Clerkship - Transfusion Medicine Lecture 2001-2007 MGH-HMSIII
10
12-3rd year medical students 4-6 h contact!yr, 4-6 hr preparation/yr
1999-2001 Pathology/Lab Medicine Examiner, Objective Skills Comprehensive Exam
20-4m year medical students 4 h contact/yr, 1-2 h preparation/yr
2007-2008 Principle Clinical Experience MGH-HMSIII
Laboratory Medicine Orientation Laboratory Medicine Resource
12-3rd year medical students 6 h contact/yr
2008-2010 Principle Clinical Experience MGH-HMSIII
Laboratory Medicine, Course Director; Lecturer
40-3rd year medical students 20 hr preparation/yr; 3 hr contact/y, 10 h preparation/y
2014,2015 Immunology, Microbiology and Lab Section Leader
contact Pathology
Formal Teaching of Residents, Clinical Fellows and Research Fellows_(post-doc~ 1991 Transfusion Medicine Rotation
Lecture Series Lecture
12 MGH pathology residents/fellows/yr
21-30 h contact/ yr, 21-30 h preparation/yr
1991-1997 Use of Specialized Blood Components in Hematology Oncology Patients
Lecture
5-7 MGH Heme-One residents/fellows per session
4-6 h contact/yr, 4-6 hr/preparation/yr
1999-2003 Blood Component Therapy Lecture 8 MGH medical ICU residents/fellows per session
4 h contact/yr, 4 h preparation/yr
I 2oo1- I CP "Outs" Conference I Discussion Leader
11
10 MGH pathology 1-3 h contact/yr, 2-10 h preparation/yr residents/fellows per session
Clinical Su 1986-1991 Supervised clinical pathology rotation for residents, St. Thomas
Hospital Vanderbilt University 5 h per week
1991- Supervise transfusion medicine rotation for pathology residents, 10 h per service week Massachusetts General Hospital
1991 Supervise blood banking/transfusion medicine elective rotation residents in podiatry, and fellows in critical care, allergy and immunology, and hematology/oncology, Massachusetts General Hospital
50 h/yr
1993- Supervise Transfusion Medicine fellows, Massachusetts 10 h per service week General Hospital
. dT .FormaIIIy Superv1se ramees 1992-1993 JefferyS. Dzieczkowski, M.D.
Associate Professor, Department of Medicine, Indiana University School of Medicine Supervised as resident and fellow.
1993 1994 Jun Teruya, M.D D.Sc. Director, Blood Bank, Children's Hospital, Associate Professor, Department of Pathology, Baylor University School of Medicine, Houston, TX Supervised as resident, fellow and junior faculty; published 3 manuscripts.
1994-1995 Michael R. Pins, M.D. Professor, Department of Pathology, Northwestern University School of Medicine, Chicago, IL Supervised as resident, fellow and junior faculty; published 3 manuscripts.
1996-1997 David M. Andrews, M.D. Director, Blood Bank and Special Coagulation Laboratories, Jackson Memorial Hospital, Assistant Professor, Department of Pathology, University of Miami School of Medicine, Miami, FL Supervised as resident, fellow and junior faculty, and have been career mentor.
1997-1998 Zbigniew M. Szczepiorkowski, M.D., Ph.D. Associate Professor, Departments of Pathology and Medicine, Dartmouth Medical School, Director, Transfusion Medicine Service and of Cellular Therapy Center, Dartmouth Hitchcock Medical Center Supervised as resident, chief resident, fellow and junior faculty, and have been career
12
I mentor; published 1 manuscript.
1999-2000 Alexander Kratz, M.D., Ph.D. Assistant Professor, Department of Pathology, Columbia University College of Physicians and Surgeons, Medical Director of the Allen Pavilion Clinical Laboratory, Associate Director of the Core Laboratory Supervised as resident, chief resident and fellow; published 1 manuscript.
2000-2001 Yashpal Agrawal, M.D., Ph.D. Associate Professor of Clinical Pathology and Laboratory Medicine, Department of Pathology, Medical College of Cornell University, Chief, Chemistry Laboratory, New York Presbyterian Hospital. Supervised as resident and fellow.
2002-2003 Quentin Eichbaum, M.D., Ph.D. Assistant Dean for Program Development; Associate Director of Transfusion Medicine; Associate Professor ofPathology; Associate Professor of Medical Education and Administration; Member, Vanderbilt Institute for Global Health. Vanderbilt University School ofMedicine Supervised as resident, chief resident, fellow and junior faculty, and have been career mentor.
Assistant Professor, of Associate Director, Blood Transfusion Service, MGH. Supervised as resident, chief resident, fellow and junior faculty, and have been career mentor; published 4 manuscripts.
2004-2005 Karnran Darabi, M.D., Dr. Med. Hematologist/Medical Oncologist, Sanford University of South Dakota Medical Center, Sioux Falls, SD Supervised as resident and fellow; 2 publications.
2005-2006 Richard Haspell, M.D., Ph.D. Assistant Professor of Pathology, Harvard Medical School, Associate Director, Blood Bank, Beth Israel-Deaconess Medical Center Supervised as fellow; published 1 manuscript.
2006-2008 Amanda Davis, M.D. Haematologist and Transfusion Specialist, The Alfred Hospital, Melbourne, Australia Supervised as fellow and have been career mentor; published 2 manuscripts.
2008-2009 Daniela S. Krause, M.D., Ph.D. Associate Professor of Pathology Institute for Tumor Biology and Experimental Therapy, University of Frankfurt
13
Supervised as resident, chief resident and fellow, and have been career mentor; published 1 manuscript; sponsored Vickery Award project.
2009-2010 Bernard Khor, M.D., Ph.D Assistant Professor, Benaroya Research Institute, University of Washington Supervised as resident, chief resident and fellow.
2011-2012 Pavan Bendapudi, M.D. Instructor of Medicine, Harvard Medical School Physician, Department of Hematology/Oncology, MGH Supervised as fellow; co-sponsored Vickery Award project
2012-2013 J. Ryan Pena, M.D., Ph.D. Instructor of Pathology, Harvard Medical School, HLA Lab Director, Assistant Blood Bank Director, Beth Israel-Deaconess Medical Center Supervised as resident, Chief Resident and fellow.
2012-2013 Siddhartha Jaiswal, M.D., Ph.D. Research and Clinical Fellow, Department of Pathology, MGH Supervised as resident, Chief Resident and fellow.
2013-2014 James Kelley, M.D., Ph.D
2014-2015 Roger Belizaire, M.D., PhD Research and Clinical Fellow, Department of Pathology, MGH Supervised as fellow.
2015-2016 Johnny Mack, M.D., M.P.H. Instructor, Department of Pathology, Harvard Medical School, Assistant Director, Blood Transfusion Service, MGH. Supervised as fellow.
2016-2017 Stephan Kadauke, M.D., Ph.D. Fellow, Harvard Medical School Transfusion Medicine Fellowship Program Supervising as MGH based-fellow.
Formal Teaching of Peers (e.g., CME and other continuing education courses) 1987 The Blood Group Systems ofthe Glycophorins:
Mechanisms of Antigenic Diversity Lecture
VIIth Annual Conference on Recent Advances in Blood Banking, Vanderbilt University (no sponsor)
Nashville
14
1987 Transfusion Acquired AIDS Lecture IXth Annual Seminar on the Management of the Critically Ill Patient, Vanderbilt University (no sponsor)
Nashville
1992 The Blood Bank and Aortic Surgery Lecture Aortic Surgery 1992: State ofthe Art Harvard Medical School (no sponsor)
Cambridge
1994 Risks and Indications for Red Blood Cell Transfusion Lecture Management Decisions for the General Surgeon Harvard Medical School (no sponsor)
Cambridge
1996 The Costs of Transfusion Lecture Harvard Hip Course Harvard Medical School (no sponsor)
Cambridge
2000 The Transfusion of Red Blood Cells, FFP and Albumin
Lecture
Pulmonary and Critical Care Medicine Harvard Medical School
Cambridge
Usage and Abusage Respiratory and Critical Care 2001 Harvard Medical School (no sponsor)
2001 Transfusion Therapy: Is It Time for Evidence Based Medicine?
Lecture
Pulmonary and Critical Care Medicine Harvard Medical School (no sponsor)
Cambridge
2002 Transfusion Therapy in Critical Care Lecture Pulmonary and Critical Care Medicine Harvard Medical School (no sponsor)
Cambridge
2002 Blood Use and Misuse in Critical Care Lecture
Respiratory and Critical Care 2002 Harvard Medical School (no sponsor)
Boston
2002 Preoperative Autologous Blood Donation in Orthopedic Surgery
Lecture
32na Annual Advances in Hip and Knee Arthroplasty Harvard Medical School (no sponsor)
Boston
1992
15
2003 Unknown Case: Blood Bank Single presentation
Current Concepts in Clinical Pathology Harvard Medical School (no sponsor)
Cambridge
2005 Putting Platelets Back into the Refrigerator Lecture Current Topics in Blood Banking University ofMichigan (no sponsor)
Ann Arbor
2005 Transfusion Associated Circulatory Overload Lecture Current Concepts in Clinical Pathology Harvard Medical School (no sponsor)
Cambridge
2007 An 87 year old Woman with Acute Respiratory Distress during RBC Transfusion
Lecture
Applying Anatomic and Clinical Pathology to Reach a Diagnosis: A Case-Based Educational Program, Harvard Medical School (no sponsor)
Boston
2007 An 60 year old Woman with Hemolytic Anemia and Thrombocytopenia: When TTP is Not
Lecture
Applying Anatomic and Clinical Pathology to Reach a Diagnosis: A Case-Based Educational
Boston
Local Invited Presentations 1991 Blood Utilization in Urological Surgery: Alternatives to Homologous Transfusion/
Grand Rounds Department of Urology, MGH (no sponsor)
1992 Indications for Blood Component Irradiation/ Grand Rounds Department of Hematology/Oncology, MGH (no sponsor)
Transfusion in the Emergency Ward/ Grand Rounds Department of Emergency Medicine, MGH (no sponsor)
Red Blood Cell Transfusion/ Grand Rounds Department of Anesthesia, MGH (no sponsor)
Current Issues in Transfusion Medicine/ Chief Resident's Rounds Department of Anesthesia, MGH (no sponsor)
1992 The Physiology ofRed Blood Cell Transfusion/ Grand Rounds Department of Surgery, MGH (no sponsor)
1992
1992
1992
1993
1994
1994
1995
1995
1997
1998
16
CMV and Transfusion/ Grand Rounds Department of Hematology/Oncology, BWH (no sponsor)
The Glycophorin-associated Antigens of the Red Blood Cell/ Grand Rounds Department of Hematology/Oncology, BWH (no sponsor)
The Use of Albumin in Large Volume Paracentesis/ Grand Rounds Department of Medicine, MGH (no sponsor)
Massive Transfusion/ Grand Rounds Department of Anesthesia, MGH (no sponsor)
How to Carry Oxygen When You Can't Use Red Blood Cells/ Grand Rounds Department of Pathology, BWH (no sponsor)
1995 Blood Substitutes/ Grand Rounds I Department of Pathology, MGH (no sponsor) I
Risks, Indications and Alternatives of Red Cell Transfusion/ Grand Rounds Department of Obstetrics and Gynecology, MGH (no sponsor)
1996 Blood Component Therapy/ Grand Rounds I Department of Obstetrics and Gynecology, MGH (no sponsor) I
Red Blood Cell Substitutes/ Clinical Pathology Rounds Department of Pathology, MGH (no sponsor)
Transfusion Therapy: Risks and Benefits of Red Blood Cell Transfusion/ Grand Rounds Department of Urology, MGH (no sponsor)
Transfusion Support of Bone Marrow Transplantation/ Conference Bone Marrow Transplant Unit, MGH (no sponsor)
2002 I Transfusion Therapy in Bone Marrow Transplantation/ Conference I I Bone Marrow Transplant Unit, MGH (no sponsor)
Blood Component Utilization in Critical Care/ Conference Surgical Intensive Care Unit, MGH (no sponsor)
12003 I Transfusion Therapy in Acute Care/ Grand Rounds
2000
2002
I
2004
2004
2004
2008
17
I Department of Anesthesia, MGH (no sponsor)
2003 The Use ofBlood Substitutes in Jehovah's Witnesses/ Chief of Service Rounds Department of Pediatrics, MGH (no sponsor)
2003 The Use ofPolyHeme, a Blood Substitute, in Trauma/ Grand Rounds Trauma Service, MGH (no sponsor)
The Development of Blood Substitutes I Tech Lectures Department of Pathology, MGH (no sponsor)
TTP/ Residents Rounds Department of Medicine, MGH (no sponsor)
Managing the Jehovah's Witness Patient in the Intensive Care Unit/ Ethics Rounds Department of Anesthesia and Critical Care, MGH (no sponsor)
2005 What Ever Happened to Blood Substitutes? I Leukemia Rounds Department of Hematology/Oncology, MGH (no sponsor)
2006 A 25 year-old woman with relapsing fevers and recent onset of dyspnea. Case Records of the Massachusetts General Hospital/ Clinical Pathological Conference Department of Pathology, MGH (no sponsor)
2007 A 68 year old woman with anemia and jaundice/ Residents' Report Department of Medicine, MGH (no sponsor)
2008 Ethical issues in transfusion: Jehovah's Witnesses and Informed Consent/ Ethics Rounds Surgical Intensive Care Unit, MGH (no sponsor)
Informed Consent and Peripherally Inserted Central Catheters/ Lecture Intravenous Therapy Unit, MGH (no sponsor)
Assessing Tissue Ox genationl Tech Talks Department of Pathology, MGH (no sponsor)
The Clinical Effect of RBC Stora e: The Red Blood Cell Storage Duration Study Department of Cardiac Surgery, MGH (no sponsor)
The Clinical Effect ofRBC Storage: The Red Blood Cell Storage Duration Study 2009 I Department of Cardiac Anesthesia, MGH (no sponsor)
12009 I Does Age Matter: RBC Storage and Clinical Outcomes/ Tech Talks
2008
2009
I
2009
2010
2013
2014
2014
2015
2015
18
I Department of Pathology, MGH (no sponsor)
Hemoglobin Based Oxygen Carriers Interdisciplinary Hematology Conference, MGH (no sponsor)
The Clinical Effect of RBC Storage: The Red Blood Cell Storage Duration Study Interdisciplinary Hematology Conference, MGH (no sponsor)
2011 RBC Storage and Clinical Outcomes Interlaboratory Conference Grand Rounds, Department of Pathology, MGH (no sponsor)
2013 Leukapheresis in Leukemia Grand Rounds, Department of Ophthamology, Massachusetts Eye and Ear Infirmary (no sponsor)
Does the Storage Age ofRBC Affect Patient Outcomes: The Clinical Studies Clinical Pathology Rounds, BWH (no sponsor)
2013 Massive Transfusion: Pearls and Pitfalls
Anesthesia Faculty Workshop, MGH (no sponsor)
Transfusion Medicine for Anesthesiologists
The Red Cell Storage Duration Study and the Blood Transfusion Service Department of Pathology, MGH (no sponsor)
Results ofRCTs on the Clinical Effects of Red Cell Storage Department ofHematogy/Oncology, MGH (no sponsor)
RBC Storage and Patient Outcomes: What Do the Clinical Trials Tell Us? Lecture Clinical Pathology Rounds, Brigham and Women's Hospital, Boston, MA (no sponsor)
2015 The Effect of RBC Storage on Clinical Outcomes Department of Maternal/Fetal Medicine, MGH (no sponsor)
Transfusion and the Jehovah's Witness: When Ethics Collide Surgical ICU Rounds, MGH (no sponsor)
2016 RBC Storage and Patient Outcomes: What Do the RCTs Tell Us? Department of Pathology Grand Rounds, MGH (no sponsor)
j2016 ITransfusion Medicine for Anesthesiologists
2015
1987
1987
1987
1987
1988
1989
19
I Department of Anesthesia, MGH (no sponsor)
Report of Regional, National and International Invited Teaching and Presentations
R .egwnaI
1986 Surrogate Testing for Transfusion-associated Non-A, Non-B Hepatitis/ Annual Meeting Lecture Tennessee Association of Blood Banks (no sponsor)
Laboratory Support for Cardiac Transplantation! Annual Meeting Lecture Middle Tennessee Society of Medical Technologists (no sponsor)
Cardiac Transplantation! Lecture Diaclin Laboratories, Inc., Nashville, TN (nos onsor)
Infection in Cardiac Allograft Recipients/ Annual Meeting Lecture Southern Association of Clinical Microbiologists (no sponsor)
The Erythrocyte Membrane in Serology/ Annual Meeting Lecture Tennessee Association of Blood Banks (no sponsor)
1988 The Effect of Transfusion on Renal Transplantation! Annual Meeting Lecture I Tennessee Association of Blood Banks (no sponsor) I
From Mao to Now: Blood Banking in China/ Fall Meeting Lecture Tennessee Association of Blood Banks (no sponsor)
Transfusion Therapy in Emergency Medicine/ Annual Meeting Lecture Tennessee State Society of American Medical Technologists (no sponsor)
1989 Pharmacological Alternatives to Transfusion! Annual Meeting Lecture I Tennessee Association of Blood Banks (no sponsor) I
Blood Conservation Techniques/ Lecture Lourdes Hospital, Paducah, KY (no sponsor)
Modem biotechnology in blood banking/ Annual Meeting Lecture Tennessee Association of Blood Banks (no sponsor)
11991 I Rh: The old and the new/ Annual Meeting Lecture
1990
1990
1992
1994
1994
1995
1996
20
I Tennessee State Society of American Medical Technologists (no sponsor)
1992 Chagas' Disease: A case report and implications for blood banking/ Annual Meeting Lecture Massachusetts Association of Blood Banks (no sponsor)
The use of IVIg in the treatment of Guillain-Barre syndrome/ Lecture American Red Cross Blood Services, Dedham, MA (no sponsor)
A Case of Alloimmunization following Bone Allografting/ Annual Meeting Lecture 1994 I Massachusetts Association of Blood Banks, Westford, MA (no sponsor) I
Coordinating Blood Conservation Strategies/ Lecture Coral Therapeutics, Boston, MA (Coral Therapeutics)
Transfusion Transmitted CMV Infection/ Annual Meeting Lecture Rhode Island Blood Bank Society, Providence, RI (no sponsor)
1995 Changes in the 16th Edition of the AABB Standards/ Workshop Massachusetts Association of Blood Banks, Dedham, MA (no sponsor)
1995
1995 Update in Transfusion Medicine I Lecture John Boden Symposium, Middlesex Hospital, Middletown, CT (no sponsor)
Substitutes for Red Blood Cell Transfusion/ Annual Meeting Lecture Massachusetts Association of Blood Banks, Westford, MA (no sponsor)
Transfusion of Platelets, FFP and Cryoprecipitate/ Grand Rounds Emerson Hospital, Concord, MA (no sponsor)
1999 Rhode Island Blood Bank Society, Providence, RI (no sponsor)
1999 Red Blood Cell Substitutes/ Annual Meeting Lecture Maine Society for Clinical Laboratory Science, Portland, ME (no sponsor)
Progress in the Development of Blood Substitutes/ Grand Rounds Department of Pathology, Hartford Hospital, Hartford, CT (no sponsor)
12000 IBlood Substitutes I Lecture
2000
2001
2002
2004
2006
21
Transfusion Medicine 2000, American Red Cross, Blood Services, Sturbridge, MA (no sponsor)
Progress in Blood Substitutes/ Annual Meeting Lecture Massachusetts Association of Blood Banks, Westford, MA (no sponsor)
RBC Substitutes: Progress and Problems/ Grand Rounds Department of Pathology, Bay State Medical Center, Springfield, MA (no sponsor)
j2003 A Perspective on Bloodless Medicine/ Annual Meeting Lecture Massachusetts Association of Blood Banks, Westford, MA (no sponsor) I
2003 Carbohydrate Blood Group Systems, The Rh and L W Blood Groups Systems, Therapeutic Apheresis, The Direct Antiglobulin Test and the Autoimmune Hemolytic Anemias, Compatibility Testing, Massive Transfusion, Non-infectious Complications of Transfusion, Infectious Complications of Transfusion, Current Issues in Blood Substitutes, Autologous Transfusion, Transfusion of the Fetus and Neonate/ Visiting Professor (11 lectures) Department of Pathology and Laboratory Medicine, New England Medical Center, Tufts University Medical School, Boston, MA (no sponsor)
A New Paradigm for the Design of Oxygen Therapeutic Agents/ Annual Meeting
2006 Blood Substitutes/ Grand Rounds Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA (no sponsor)
Assessing Tissue Ox genation/ Annual Meeting Lecture Massachusetts Association of Blood Banks, Westford, MA (no sponsor)
2006 Unusual Blood Groups in Obstetrics/ C.M. Asuncion Lecture Departments of Pathology and Laboratory Medicine and Obstetrics and Gynecology, St. Francis Hospital and Medical Center, University of Connecticut School of Medicine, Hartford, CT (no sponsor)
j2007 The Bombay Phenotype: One Patient, Many Lessons/ Annual Meeting Lecture Massachusetts Association of Blood Banks, Westford, MA (no sponsor)
2007 Ask the Customer: Assessing Tissue Oxygenation/ Annual Meeting Lecture American Society of Clinical Laboratory Science: Central New England. Providence, RI (no sponsor)
/2008 / Ask the Customer: Assessing Tissue Oxygenation/ Annual Meeting Lecture
2009
22
INortheast Clinical Laboratory Conference, Portland, ME (no sponsor)
A Perennial Controversy: Does RBC Storage Affect Clinical Outcomes? American Red Cross Transfusion Medicine Seminar, Worcester, MA (no sponsor)
2010 RBC Storage and Clinical Outcomes: The State of the Controversy IAnnual Meeting Lecture Massachusetts Association of Blood Banks, Westford, MA (no sponsor)
2010 RBC Storage and Clinical Outcomes: The Red Cell Storage Duration Study (RECESS) Lecture American Red Cross Blood Services, New England, Dedham, MA (no sponsor)
2010 Clinical Effects of RBC Storage and the Red Cell Storage Duration Study (RECESS) Lecture Medical Advisory Committee, American Red Cross Blood Services, New England, Dedham, MA (no sponsor)
2010 The Effect ofRBC Storage on Patient Outcomes: Does Age Matter? Lecture I 2010 Northeast Laboratory Conference, Portland, ME (no sponsor) I
2011 Annual Meeting, American Society for Clinical Laboratory Science- Central New England, Providence, RI (no sponsor)
2013 There were Three Dames from Quebec : Three Patients, Many Lessons I Lecture 2013 Annual Meeting, American Society for Clinical Laboratory Science- Central New England, Providence, RI (no sponsor)
2013 Massive Transfusion and Transfusion Protocols I Annual Meeting Lecture I Massachusetts Association of Blood Banks, Westford, MA (no sponsor) I
2014 Massive Transfusion: Improving Patient Outcomes? Lecture 2014 Annual Meeting, American Society for Clinical Laboratory Science- Central New England, Providence, RI (no sponsor)
Is it 'Old' or is it "Vintage'? The Red Cell Storage Duration Study: RECESS I Lecture12014 American Red Cross Transfusion Medicine Seminar, Worcester, MA (no sponsor I
The Red Cell Storage Duration Study: RECESS I Lecture Massachusetts Association of Blood Banks, Westford, MA (no sponsor)
2015
2015
1988
1990
1990
23
2015 The Red Cell Storage Duration Study: RECESS I Lecture 2015 Annual Meeting, American Society for Clinical Laboratory Science- Central New England, Providence, RI (no sponsor)
RBC Storage and Patient Outcomes: What Do the Clinical Trials Tell Us? Lecture 2015 Northeast Laboratory Conference, Portland, ME (no sponsor)
2016 The Newest Clinical Trials in Red Cell Storage: Not a TOTAL RECAP of RECESS I Lecture 2016 Annual Meeting, American Society for Clinical Laboratory Science- Central New England, Providence, RI (no sponsor)
2016 Thought You Were ABLE to take a RECESS?: Here Comes a TOTAL RECAP I Lecture 2016 Annual Meeting, Massachusetts Association ofBlood Banks, Westford, MA (no sponsor)
National
Characterization of Human Fibronectin Glycopeptides from Cystic Fibrosis and Control Skin Fibroblasts/ Ground Rounds
The ABH and Related Blood Group Systems: Beyond ABO/ Lecture Wilford Hall Medical Center, Lackland AFB, TX (no sponsor)
The Rh Blood Group System: Serology and Biochemistry/ Lecture Wilford Hall Medical Center, Lackland AFB, TX (no sponsor)
Leukodepletion I Annual Meeting Lecture 11993 Tennessee Association of Blood Banks, Nashville, TN (no sponsor)
Reducing donor exposures I Annual Meeting Lecture Tennessee Association of Blood Banks, Nashville, TN (no sponsor)
Changes in the 16th Edition of the AABB Standards I Audioconference American Association of Blood Banks (no sponsor)
1994 Changes in the 16th Edition of the AABB Standards I Inspectors Workshop/ Annual Meeting Lecture American Association of Blood Banks, San Diego, CA (no sponsor)
I
1993
1994
1995
1998
1998
1998
1999
I
24
1995 The Role of Blood Substitutes in Transfusion Medicine I Annual Meeting Lecture I Tennessee Association of Blood Banks, Chattanooga, TN (no sponsor)
Current Progress in Blood Substitutes I Annual Meeting Lecture American Association of Blood Banks, New Orleans, LA (no sponsor)
The Impact of Red Blood Cell Substitutes on Blood Banking I Annual Meeting Lecture New York Association of Blood Banks, Albany, NY (no sponsor)
1998 The Development of Red Blood Cell Substitutes I Grand Rounds Department of Pathology and Laboratory Medicine, University ofNorth Carolina, Chapel Hill, NC (no sponsor)
Update on Red Blood Cell Substitutes I Annual Meeting Lecture North Carolina Association of Blood Banks, Chapel Hill, NC (no sponsor)
Overview of Oxygen-carrying Blood Substitutes I Annual Meeting Lecture American Association ofBlood Banks, Philadelphia, PA (no sponsor)
Progress in the Development of Red Blood Cell Substitutes I Annual Meeting Lecture Tennessee Association of Blood Banks, Nashville, TN (no sponsor)
Department of Pathology, Northwestern University School of Medicine, Chicago (no sponsor)
2000-2012 Review of Blood Banking and Transfusion Medicine I Annual Review Course Lectures (3 hr) RISE Comprehensive Review Course, Boston, MA (American Society of Clinical Pathologists)
2001 Advances in Artificial Blood Therapy I Annual Meeting Lecture I Tennessee Association of Blood Banks, Knoxville, TN (no sponsor) I
2001 Carbohydrate Blood Group Systems, The Rh and L W Blood Groups Systems, Therapeutic Apheresis, The Direct Antiglobulin Test and the Autoimmune Hemolytic Anemias, Compatibility Testing, Massive Transfusion, Non-infectious Complications of Transfusion, Blood Component Therapy/ Visiting Professor (8 lectures) Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH (no sponsor)
Error and Accident Reporting to the FDA I Annual Meeting Lecture I American Association of Blood Banks, San Antonio, TX (no sponsor) I
2001
2002
2002
2003
2003
25
2002 A Prospective, Randomized Clinical Trial of Universal Leukoreduction I Grand Rounds Department of Pathology, Northwestern University School of Medicine, Chicago (no sponsor)
2002 Blood Substitutes in the Hospital Oxygen Therapeutics and Transfusion Alternatives Conference I American Association ofBlood Banks, Arlington, VA (no sponsor)
RBC Substitutes: Progress and Problems I Annual Meeting Lecture American Society for Artificial Internal Organs , New York, NY (no sponsor)
Progress in the Development of Blood Substitutes I Annual Meeting Lecture American Society for Clinical Laboratory Science, Orlando FL (no sponsor)
Current Status of the Development of RBC Substitutes I Annual Meeting Lecture American Association of Blood Banks, Orlando, FL (no sponsor)
12002
I
2002 A Prospective, Randomized Clinical Trial of Universal Leukoreduction I Grand Rounds Department of Pathology, University oflowa School of Medicine, Iowa City, IA (no sponsor)
Bloodless Medicine in the 21st Century I Annual Meeting Lecture Tennessee Association of Blood Banks, Memphis, TN (no sponsor)
Infectious Complications of Transfusion I Annual Meeting Lecture Infusion Nurses Society, Nashville, TN (no sponsor)
2003 Synthetic Oxygen Carriers, Laboratory Technology Issues I Audioconference Teleconference Network ofTexas, University of Texas Health Care Center, San Antonio, TX (no sponsor)
2003 Alloantibody Identification I Annual Review Course Lecture RISE Comprehensive Review Course, Chicago, IL (American Society of Clinical Pathologists)
2003 Current Status of the Development of RBC Substitutes I Annual Meeting Lecture I American Association of Blood Banks, San Diego, CA (no sponsor) I
A New Paradigm for the Design of Oxygen Therapeutic Agents I Lecture Update in Transfusion Medicine Council of Hospital Blood Bank Directors of the
2003
2005
2005
2006
2006
2009
2010
2010
26
I Greater New York Region, New York, NY (no sponsor)
2005 Blood Substitutes: New Insights into Oxygen Delivery I Grand Rounds Department of Pathology, Texas Children's Hospital/Baylor University School of Medicine; Houston, TX (no sponsor)
2005 Platelet Galactosylation and Cold Storage I Coagulation Conference Department of Pathology, Texas Children's Hospital/Baylor University School of Medicine; Houston, TX (no sponsor)
Blood Substitutes: The Road Ahead I Annual Meeting Lecture American Association of Blood Banks, Seattle, WA (no sponsor)
Therapy with Immunoglobulins: Applications for Monoclonal Antibodies I Annual Meeting Lecture Intravenous Nursing Society, Atlanta, GA (no sponsor)
Assessing Tissue Oxygenation I Grand Rounds Lecture Department of Pathology, Northwestern University, Chicago, IL (no sponsor)
Blood Substitutes: New Insights into Oxygen Delivery I Annual Meeting Lecture Blood Bank Association of New York State, New York, NY (no sponsor)
The Fresh Blood Controversy I Annual Keynote Address New Jersey Society of Blood Bank Professionals, New Brunswick, NJ (no sponsor)
RBC Storage and Clinical Outcomes: The State of the Controversy I lecture Brown University: New Frontiers in Transfusion Medicine, Providence, RI, (no sponsor)
The Red Cell Storage Duration Study: RECESS I Annual Meeting 'Hot Topic' Lecture American Association of Blood Banks, Baltimore, MD, (no sponsor)
2010 RBC Storage and Clinical Outcomes: The State of the Controversy I Grand Rounds Department of Laboratory Medicine, Washington University, St. Louis, MO (no sponsor)
2011 Old or Vintage? The Effects of Red Blood Cell Storage on Clinical Outcomes I Annual Meeting Lecture New York Association of Blood Banks, Verona, NY (no sponsor)
2011 Red Blood Cell Storage and Clinical Outcomes I Annual Meeting Lecture I Florida Association of Blood Banks, Jacksonville, FL (no sponsor) I
I
I
2012
2013
2014
2014
2015
27
2011 The Red Blood Cell Storage Study (RECESS) I Grand Rounds Department of Laboratory Medicine, University of California, San Francisco, San Francisco, MA (no sponsor)
2011 The Red Blood Cell Storage Study (RECESS) I Lecture XIII International Symposium on Blood Substitutes and Oxygen Therapeutics, Boston, MA (no sponsor)
Red Blood Cell Storage and Clinical Outcomes I Teleconference Lecture University of Texas Teleconference Network, San Antonio, TX (no sponsor)
2012 Red Blood Cell Storage and Clinical Outcomes I Annual Meeting Lecture I American Association of Blood Banks, Boston, MA, (no sponsor) I
Massive Transfusion I Teleconference Lecture University of Texas Teleconference Network, San Antonio, TX (no sponsor)
2013 The RECESS Ancillary Study (RECAP) I Annual Steering Committee Meeting Transfusion Medicine and Hemostasis Clinical Trials Network, Arlington, VA (no sponsor)
Overview of the APC PRODSIAFPIASCP Lab Management Curriculum and the PCTr'"'"'" I
Does Red Blood Cell Age Matter? I Annual Meeting Lecture Tennessee Association of Blood Banks, Nashville, TN (no sponsor)
2014 Overview of the APC PRODSIAFPIASCP Lab Management Curriculum and the ACGME Lab Management Milestones I Lecture Pathology Program Directors Annual Meeting, Boston, MA (no sponsor)
Informed Consent for Transfusion/ Webinar American Association of Blood Banks, (no sponsor)
International
1988 Transfusion Transmitted Non-A, Non-B Hepatitis I Lecture Red Cross Blood Center, Beijing; Red Cross Blood Center, Wuhan, PR China (no sponsor)
198 8 The Biochemical Basis of Erythrocyte Serology I Lecture Union Hospital ofTonji Medical University, Wuhan, PR China (no sponsor)
2005
2013
28
1988 Transfusion Associated AIDS: An Update I Lecture Red Cross Blood Center, Beijing; First Medical College, Changsha, PR China (no sponsor)
1999 An open-label, Randomized, Parallel Group Study to Compare the Efficacy and Safety ofPerioperative Procrit (Epoetin alfa) and Autologous Predeposit to Reduce the Risk of Transfusion in Subjects undergoing Major, Elective Orthopedic Surgery I Lecture Fourth Congress of the European Federation ofNational Associations of Orthopaedics and Traumatology, Brussels, Belgium (no sponsor)
2002 The Present and Future for Blood Substitutes I Lecture XXXV Congress of the Italian Society of Blood Transfusion and Immunohematology, Leece, Italy (no sponsor)
Qu'est il arrive aux substituts du sang? I What happened to blood substitutes?/ Lecture EuroSAT 2005, Paris, France (no sponsor)
2012 Stored Red Blood Cells : Old or Vintage ? I Annual Meeting Lecture Hematology Society of Australia and New Zealand; Melbourne, Australia (no sponsor)
2012 Patient outcomes and Red Blood Cell Storage: The Clinical Studies I Annual Meeting Lecture
2012 There were Three Dames from Quebec : Limericks and Rare Blood Groups I Annual Meeting Master Class Hematology Society of Australia and New Zealand; Melbourne, Australia (no sponsor)
Managing Major Hemorrhage: The North American Perspective I Keynote Address Blood Group Serology 2013; Reading, UK (no sponsor)
Does the Storage Age of RBC Affect Patient Outcomes: The Clinical Studies I Lecture12013 Blood Group Serology 2013; Reading, UK (no sponsor) I
2013 Transfusion Medicine Support for Stem Cell Transplantation I Lecture Dhaka Medical College Hospital; Dhaka, Bangladesh (no sponsor)
The Clinical Effects of Storing Red Blood Cells: What do the Randomized Controlled Clinical Trials Tell Us? I Lectures University of Tehran Medical School, Tehran; Iranian Hematopathology Congress, Shiraz, Iran (no sponsor)
2016
2016
29
Red Blood Cell Storage Changes: What is the Impact on Patients? I Lecture Iranian Hematopathology Congress,Shiraz, Iran (no sponsor)
2016 Compatibility Testing and Alloantibody Identification: A Systematic Approach I Lecture Iranian Hematopathology Congress, Shiraz, Iran (no sponsor)
2016 Laboratory Medicine Training in the United States I Lecture and Round Table
Iranian Hematopathology Congress, Shiraz, Iran (no sponsor)
Report of Clinical Activities and Innovations
Current Licensure and Certification 1984- 1992 Pennsylvania Medical License 1985 American Board of Pathology Certificate - Clinical Pathology 1986-2005 Tennessee Medical License 1986 US Drug Enforcement Administration License 1987 American Board of Pathology Certificate - Blood Banking 1991 - Massachusetts Medical License 1991 - Massachusetts Controlled Substances Practitioner License
ca. 17 wkslyr
1991 Gray 1 Transfusion/Infusion Unit 5 dlwk for ca. 1 7 Inpatient Units
Therapeutic Apheresis wkslyr + emergencies
1991 5 dlwk for ca. 1 7 Collection Peripheral Blood Stem Cell Gray 1 Transfusion/Infusion Unit
wkslyr 1991 Consults - transfusion Gray 2 Blood Bank 5 dlwk for ca. 1 7
reactions serology, massive wkslyr + emergencies transfusion, thrombosis, use of clotting factors and IVIg
Report of Scholarship
Peer-Reviewed Publications
Research Investigations
1. Holstein TJ, Stowell CP, Quevedo WC, Jr, Zacaro RM, Bieneke TC. Peroxidase, protyrosinase and the multiple forms oftyrosinase in mice. Yale J Bioi Med 1973;46:560-71.
30
2. Hoess RH, Smith HH, Stowell CP. A genetic analysis of peroxidase isozyrnes in two species of Nicotiana. Biochern Genetics 1974;11:319-23.
3. Lee YC, Stowell CP, Krantz MJ. 2-Irnino-2-rnethoxyethyl1-thioglycosides: New reagents for attaching sugars to protein. Biochemistry 1976;15:3956-63.
4. Krantz MJ, Holtzman NA, Stowell CP, Lee YC. Attachment ofthioglycosides to proteins: Enhancement ofliver membrane binding. Biochemistry 1976;15:3963-8.
5. Stowell CP, Kuhlenschrnidt TB, Hoppe CA. A :fluorescarnine assay for sub-microgram quantities of protein in the presence of Triton X-100. Analyt Biochern 1978;85:572-80.
6. Stowell CP, Lee YC. The binding ofD-glucosyl-neoglycoproteins to the hepatic asialoglycoprotein receptor. J Biol Chern 1978;253:6107-10.
7. Stowell CP, Lee YC. Preparation of some new neoglycoproteins by amidination of bovine serum albumin using 2-irnino-2-rnethoxyethyl 1-thioglycosides. Biochemistry 1980; 19:4899904.
8. Stowell CP, Lee RT, Lee, YC. Studies on the specificity of rabbit hepatic carbohydrate-binding protein using neoglycoproteins. Biochemistry 1980;21 :4904-8.
9. Schlesinger PH, Rodman JS, Doebber TW, Stahl PD, Lee YC, Stowell CP, Kuhlenschrnidt TB. The role of extra-hepatic tissues receptor-mediated plasma clearance of glycoproteins
rnannose 1
10. Stowell CP, Scanlin TF, Glick MC. Characterization of human fibronectin glycopeptides from cystic fibrosis and control skin fibroblasts. Carbohydrate Res 1986; 151 :279-92.
11. Wang Y-M, Hare TR, Won R, Stowell CP, Scanlin TF, Glick, MC, Hard K, van Kuik JA, Vliegenthart JFG. Additional fucosyl residues on membrane glycoproteins but not a secreted glycoprotein from cystic fibrosis fibroblasts. Clinica Chirnica Acta 1990;188:193-210.
12. Cher LM, Hochberg FH, Teruya J, Nitschke M, Valenzuela RF, Schrnahrnann, JD, Herbert M, Rosas HD and Stowell CP. Therapy for paraneoplastic neurologic syndromes in six patients with Protein A column irnmunoadsorption. Cancer, 1995:75:1678-83.
13. Teruya J, Pins MR, and Stowell CP. Effectiveness of Protein A column treatment with paraneoplastic neurologic syndromes. Jpn J Apheresis, 1995; 14:51-2.
14. Pins MR, Saidrnan SL, Cosirni BA, Jennings SH, Stowell CP. Accelerated acute rejection of an apparent A2 renal allograft in an 0 recipient; Report of a case with flow cytornetric analysis. Transplantation, 1997;63:984-8.
15. Lee SJ, Liljas B, Churchill WH, Popovsky MA, Stowell CP, Cannon ME, Johannesson M. Perception and preferences of autologous blood donors. Transfusion, 1998;38:757-63.
31
16. Stowell CP, Chandler H, Jove M, Guilfoyle M, Wacholtz MC. An open-label, randomized study to compare the safety and efficacy of peri operative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedics, 1999;22:s105-s112.
17. Corless IB, Stowell CP, Fulton R, Weeks OD. Perspectives in conflict: the response to transfusion-associated AIDS. AIDS and Public Policy Journal 1999;14:47-67.
18. Dzik WH, Anderson JK, O'Neill EM, Assrnan SF, Kalish LA, Stowell CP. A prospective, randomized clinical trial ofuniversalleukoreduction. Transfusion 2002;42: 1114-22.
19. LinetteGP, ZhangD, Hodi FS, Jonasch EP, Longerich S, Stowell CP, Webb I, Daley H, Soiffer RJ, Cheung AM, Eapen S, Fee SV, Rubin KM, Haluska FG. Hyper-immunization utilizing autologous dendritic cells pulsed with the melanoma associated antigen gp 1 00-derived G2809V peptide elicits CD8+ immunity. Clin Cane Res. 2005; 11:7692-9.
20. Melanson S, Stowell CP, Flood JG, LewandrowskiEL, ZakRJ, Lewandrowski KB. Does blood donor history accurately reflect the use of prescription medications?: a comparison of donor history and serum toxicological analysis. Transfusion. 2006;46: 1402-7.
21. Cserti C, Haspel R, Stowell C, Dzik W. Light chain removal by plasmapheresis in myelomaassociated renal failure. Transfusion. 2007;47:411-4.
or Is a "-'""''"'"" injury prevention strategy. Transfusion. 2008;48:2549-58.
23. Stowell C, Trieu M, Chuang H, Katz N, Quarrington C. Ultrasound enabled topical anesthesia for pain reduction of phlebotomy for whole blood donation. Transfusion. 2009;49:146-53.
24. Davis A, Makar R, Stowell C, Kuter D, Dzik S. ADAMTS13 binds to CD36: a potential mechanism for platelet and endothelial localization of ADAMTS13. Transfusion. 2009;49:20613.
25. Staropoli JF, Stowell CP, Tuncer HH, Marques MB. An inquiry into the relationship between ABO blood group and TTP. Vox Sanguinis. 2009;96:344-8.
26. Stowell CP, Jones S, Enny C, LangholffW, Leitz G. An Open-Label, Randomized, ParallelGroup Study of Peri operative Epoetin Alfa Versus Standard of Care for Blood Conservation in Major Elective Spinal Surgery: Safety Analysis. Spine. 2009;34:2479-85.
27. Krause DS, Spitzer TR, Stowell CP. The concentration of soluble CD44 is increased in hematopoietic stern cell grafts of patients with acute myeloid leukemia, multiple myeloma and Non-Hodgkin lymphoma. Arch Pathol Lab Med. 2010;134:1033-8.
32
28. Makar RS, Saidman SL, Stowell CP, Lee H, Powers A. Analysis of cut-offs for screening sensitized blood donors for HLA alloantibodies using a cytometric microbead assay. Transfusion. 2011;51:166-74.
29. Baron DM, Yu B, Lei C, Bagchi A, Beloiartsev A, Stowell CP, Steinbicker A, Malhotra JR, Bloch KD, Zapol WM. Pulmonary hypertension in lambs transfused with stored blood is prevented by breathing nitric oxide. Anesthesiology 2012;116:637- 47.
30. Berra L, Coppadoro A, Yu B, Lei C, Spagnolli E, Steinbicker AU, Bloch KD, LinT, Sammy FY, Warren HS, Fernandez BO, Feelisch M, Dzik WH, Stowell CP, Zapol WM. Transfusion of stored autologous blood alters reactive hyperemia and circulating nitrite levels in healthy volunteers. Anesthesiology 2012;117:56-63.
31. Baron DM, Beloiartsev A, Nakagawa A, Martyn T, Stowell CP, Malhotra JR, Mayeur, C, Bloch KD, Zapol WM. Adverse effects of hemorrhagic shock resuscitation with stored blood are ameliorated by inhaled nitric oxide in lambs. Crit Care Med. 2013; 41:2492-501.
32. Branda J, Dighe A, Dzik W, Ferraro M, Flood J, Lee-Lewandrowski E, Makar R, Mandokolathur M, Rosenberg E, Saidman S, Sluss P, Sohani A, Stowell C, VanCott E. Lewandrowski K. The practice of clinical pathology: a quantitative description of laboratory director activities at a large academic medical center. Am J Clin Path. 2014; 142:144-9.
Y, C, J, C, W, Sobrin L. A man with paraneoplastic retinopathy plus small fiber polyneuropathy associated with Waldenstrom's macroglobulinemia (lymphoplasmacytic lymphoma): insights into mechanisms. Ocular Immunol Inflam. 2014;21:1-5.
34. Berra L, Pinciroli R, Stowell CP, Lin W, Yu B, Fernandez B, Feelisch M, Mietto C, Hod EA, Chipman D, Scherrer-Crosbie M, Bloch KD, Zapol WM. Autologous transfusion of stored red blood cells increases pulmonary artery pressure. Amer J Resp Crit Care Med. 20 14; 190:800-7.
35. Steiner M, Ness, P, Assmann S, Triulzi D, SloanS, Delaney M, GrangerS, Bennett-Guerrero E, Blajchman M, Scavo V, Carson J, Levy J, Whitman G, D'Andrea P, Pulkrabek S, Ortel L, Bornikova L, Raife T, Puca K, Kaufman R, Nuttall G, Young P, Youssef S, Engelman R, Greilich P, Miles R, Josephson C, Bracey A, CookeR, McCullough J, Hunsaker R, Uhl L, McFarland J, Park Y, Cushing M, Klodell C, Karanam R, Roberts P, Dyke C, Hod E, Stowell CP. Effects of red-cell storage duration on patients undergoing cardiac surgery. New Engl J Med. 2015; 372:1419-29.
36. McCullough J, Goldfinger D, Gorlin J, Riley W, Sandhu H, Stowell C, Ward D, Clay M, Pulkrabek S Chrebtow V, Stassinopoulos A. Cost implications of implementation of pathogeninactivated platelets. Transfusion. 2015; 55:2312-20.
33
37. Mackenzie DC, KhanNA, Blehar D, GlazierS, Chang Y, Stowell CP, Noble VE, Liteplo AS. Carotid flow time changes with volume status in acute blood loss. Ann Emerg Med. 2015;66:277-82.
38. Bendapudi PK, Ang LA, Hamdan A, Uhl L, Kaufman R, Stowell C, Dzik W, Makar RS· Impact of severe ADAMTS 13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative. Br J Haematol2015;17:836-44.
39. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, Ddungu H, Kyeyune D, Musisi A, Opoka R, Stowell CP, Dzik WH. Effect of transfusion of red blood cells with longer vs. shorter storage duration on elevated blood lactate levels in Ugandan children with severe anemia: the TOTAL randomized trial. J Amer Med Assoc. 2015;314:2514-23.
40. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, Ddungu H, Kyeyune D, Musisi A, Opoka R, Stowell CP, Dzik WH. B-type natriuretic peptide and plasma hemoglobin levels following transfusion of short-storage vs. longer-storage red blood cells: results from the TOTAL randomized trial. Amer Heart J. 2016;183:129-136.
41. Li A, Makar RS, Hurwitz S, Uhl L, Kaufman RM, Stowell CP, Dzik WH, Bendapudi PK. Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS 13 deficiency: a propensity score
study. Transfusion. 2016;56:2069-77.
Dhabangi A, Ainomugisha Cseiii-Gazdewich Ddungu Kyeyune Stowell CP, Dzik WH. Cerebral oximetry in Ugandan children with severe anemia: clinical categories and response to transfusion. J Amer Med Assoc Pediatrics. 20 16; 170:995-1002.
43. Yeh AC, Khan MA, Harlow J, Biswas AR, Akter M, Ferdous J, Ara T, Islam M, Caron M, Barron AM, Moran J, Brezina M, Saha A, Kamruzzaman MD, Nazneen H, Marshall A, Afrose S, Stowell CP, Preffer F, Bangsberg D, Goodman AK, Attar E, McAfee S, Spitzer TR, Dey BR. Hematopoietic stem cell transplantation in the resource-limited setting: establishing the first bone marrow transplant unit in Bangladesh. J Global Oncology. 2017. In press.
44. Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, Hamdan A, Li A, Brunner AM, Ganser JM, Viswanathan S, Kaufman RM, Uhl L, Stowell CP, Dzik WH, Makar RS. Derivation and external validation of a predictive score for the rapid assessment of patients with thrombotic microangiopathies: the PLASMIC Score. Lancet Haematol. 2017. In press.
45. Stowell CP, Whitman G, GrangerS, Gomez H, Assmann SF, Massey M, Shapiro N, Steiner ME, Bennett-Guerrero E. The impact of red blood cell storage duration on tissue oxygenation in cardiac surgery: RECESS ancillary physiologic study (RECAP). J Thorac Cardiovasc Surg. 2017;153: 610-619.
34
46. Delaney M, Stark PC, Suh M, Triulzi DJ, Hess JR, Steiner ME, Stowell CP, Sloan SR. Massive transfusion in cardiac Surgery: the impact of blood component ratios on clinical outcomes and survival. Anesthesia Analgesia. 2017. In press.
Other peer-reviewed publications
1. Nachamkin I, Stowell CP, Skalina D, Jones AM, Roop R Smibert R. Campylobacter larides causing bacteremia in an immunocompromised host. Ann Int Med 1984; 101:55-7.
2. Cheek R, Harmon J, Stowell, CP. Red blood cell alloimmunization following a bone allograft. Transfusion, 1995;35:507-9.
3. Darabi K, Abdel-Wahab 0, Stowell CP, Sepehr A. An 87-year-old woman with respiratory distress and alveolar hemorrhage after transfusion. Chest. 2006;130;1612-6.
4. Davis A, Mandai R, Johnson M, Makar R, Stowell C, Dzik S. Teaching Cases in Transfusion Medicine: A touch ofTRALI. Transfusion 2008;48:541-5.
Non-Peer Reviewed Scientific or Medical Publications/Materials
Reviews, chapters, monographs and editorials
1. Lee Neoglycoproteins: preparation application glycoproteins. In: Tipson RS, Horton D, eds. Adv in carbohydrate chemistry and biochemistry. New York: Academic Press, 1980;37:225-81.
2. Lee YC, Lee RT, Kawaguchi K, Stowell CP. Structural requirements of rabbit hepatic lectin specific for galactose and N-acetylgalactosamine. In: Yamaka T, Osawa T, and Handa S, eds. Glycoconjugates. Tokyo: Japan Scientific Societies Press, 1981;388.
3. Stowell CP, Lee YC. Preparation ofneoglycoproteins using 2-imino-2-methoxyethyl thioglycosides. In: Ginsburg V, ed. Methods enzymol. 1982;83:278-88.
4. Stowell CP, Lee YC. Attachment of sugars to proteins by amidination. In: BeMiller JN, Whistler, RL, Shaw, DH, eds. Methods in carbohydrate chemistry. New York: John Wiley & Sons, Inc. 1983;9: 173-8.
5. Stowell CP. When to pull the trigger. Making the decision to transfuse red blood cells. Laboratory Medicine, 1995:26:55-62.
6. Pins MR, Teruya J, Stowell CP. HIV testing and case detection: Pragmatic and technical issues. In: Medical Management of AIDS in Women. eds: Cotton, DJ, Watts, DH. Wiley-Liss, Inc., 1996, pp. 163-75.
35
7. Stowell CP. The benefits of transfusion. In: Stowell CP, ed. Informed Consent for Blood Transfusions. 2nd ed. Bethesda: American Association of Blood Banks, 1997: pp. 55-66.
8. Lane TA, Sniecinski I, Stowell CP. Informed consent policies and procedures. In: Stowell CP, ed. Informed Consent for Blood Transfusions. 2nd ed. Bethesda: American Association of Blood Banks, 1997: pp. 79-110.
9. Stowell CP. Red blood cell transfusion of the immune-compromised patient. In: Reid MR, Nance ST, eds. Red Blood Cell Transfusion: A Practical Guide. Towata, NJ: The Humana Press Inc, 1997: pp. 71-87.
10. Stowell CP, Tomasulo P. The impact ofblood substitutes on blood banking worldwide. In: Rudolph AS, Rabinovici R, Feuerstein G, eds. Red blood cell substitutes: basic principles and clinical applications. New York: Marcel Dekker, 1998: pp. 1-16.
11. Stowell CP, Giordano G, Renner S, Thurer RL, WeiskopfR. An annotated bibliography on autologous transfusion. Transfusion 1998:38;400-9.
12. Szczepiorkowski ZM, Stowell CP. Red blood cell substitutes. In: Linden J, Bianco C, eds. Blood Safety and Surveillance. New York: Marcel Dekker, Inc., 2001, pp. 543-67.
13. Stowell CP, Levin J, Spiess BD, Winslow RM. Progress in the Development of Blood Substitutes. Transfusion 2001 ;41: 287-99.
lnt,orn1ed consent Transfusion Medicine. San Diego: Academic Press, 2001, pp. 345-8.
15. Stowell CP. Red Blood Cell Substitutes. In: Simon T, Dzik W, Snyder E, Stowell C, Strauss R, eds. Principles of Transfusion Medicine. 3rd ed. Baltimore: Lippincott, Williams and Wilkins: Philadelphia, 2002, 165-177.
16. Stowell CP, Haas JJ, Laposata M. Blood Transfusion Medicine in Laboratory Medicine. In: Laposata M, ed. Clinical Pathology in the Practice of Medicine. M. Laposata ed. 1st Eed. Chicago: ASCP Press, 2002, 326-44.
17. Stowell CP. Hemoglobin based oxygen carriers. Curr Opin Hematol2002;9:537-43.
18. Dong Q, Stowell CP. Blood substitutes: what they are and how they might be used. Pathol Patterns Reviews Am J Clin Pathol2002;118 (Suppll):S71-S80.
19. Wu D, Stowell CP. Prion diseases: Recent developments towards diagnostic tests. Pathol Patterns Reviews Am J Clin Pathol2003;119 (Suppl2):Sl-S7.
20. Dzik WH, Stowell CP. Transfusion and coagulation issues in trauma. In Sheridan RL, ed. Massachusetts General Trauma Handbook, Philadelphia: Lippincott, Williams and Wilkins, 2003, 128-47.
36
21. Makar RS, Stowell CP. West Nile Virus; an emerging infection in transfusion medicine. Clin Microbial Newsletter 2004;26:65-70.
22. Stowell CP. The search for a blood substitute. Blood Bulletin. 2004;7:1-3.
23. Stowell CP. Whatever happened to blood substitutes? Editorial. Transfusion. 2004;44: 1403-4.
24. Stowell CP. Qu'est il arrive aux substituts du sang? I What happened to blood substitutes? Transf Clin Biol. 2005; 12:3 7 4-9.
25. Stowell CP. Transfusion management for surgery of the spine. In Brantigan JW, ed., Intervertebral fusion using carbon-fiber reinforced polymer implants: principles, implants, techniques, and case examples." St. Louis: Quality Medical Publishers, 2006, pp. 1-26.
26. Stowell CP. Therapy with immunoglobulins: applications for monoclonal antibodies. J Infus Nursing. 2006; 29:S29-S44.
27. Stowell CP. Infonned consent for patients: blood transfusion and cellular therapies. In: Stowell CP, Sazama K, eds. Informed Consent in Blood Transfusion and Cellular Therapies: Patients, Donors and Research Subjects. Bethesda: AABB Press, 2007, pp. 59-112.
a
29. Stowell The Regulation of Oxygen Delivery. In: Simon T, Snyder E, Solheim B, Stowell C, Strauss R, eds. Principles of Transfusion Medicine. 4rd ed. Boston: Blackwell Publishing Inc., 2009. pp.29-53.
30. Cote C, Grabowski E, Stowell CP. Strategies for Blood Product Management and Reducing Transfusions. In: Cote C, Todres I, Ryan F, Goudsouzian N, eds. A Practice of Anesthesia for Infants and Children, 4th ed., W.B. Saunders Co., 2009. pp. 195-219.
31. Stowell CP. All politics, and oxygenation, are local: decision making and red blood cell transfusion. Editorial. Transfusion. 2009;49:620-1.
32. Steiner ME, Stowell CP. Does red blood cell storage affect clinical outcome? When in doubt, do the experiment. Editorial. Transfusion. 2009;49: 1286-90.
33. Stowell CP, Haas JJ. Transfusion Medicine. In: Laposata M, ed. Clinical Pathology in the Practice ofMedicine. 2nd Ed., 2010, 271-94.
34. Stowell CP. Effects of storage on the biology and clinical efficacy of the banked red blood cell. Transfus Apher Sci. 2010;43:45-7.
37
35. Steiner M, Assman S, Levy J, Marshall J, Pulkrabek S, SloanS, Triulzi D, Stowell CP. Addressing the question of the effect ofRBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS). Transfus Apher Sci. 2010;43: 107-16.
36. Blajchman M, Glynn S, Josephson C, Kleinman S, for the State-of-the Science Symposium Transfusion Medicine Committee*. Clinical Trial Opportunities in Transfusion Medicine: Proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium.Tranfus Med Rev. 2010; 24: 259-285. (*Member of Surgical Issues Subcommittee cited in Appendix.)
37. Umlas J, Stowell CP. The Blood Transfusion Service. In: Louis DN, Young R, eds. Keen minds to explore the dark continents of disease : a history of the pathology services at Massachusetts General Hospital, Boston, Mass. Massachusetts General Hospital, 2011.
38. Josephson CD, Glynn SA, Kleinman SH, Blajchman MA; State-of-the Science Symposium Transfusion Medicine Committee*. A multidisciplinary "think tank": the top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institutesponsored 2009 state-of-the-science symposium. Transfusion. 2011;51(4):828-41. (*Member of Surgical Issues Subcommittee cited in Appendix.)
39. Weiss RL, McKenna BJ, Lord-ToofM, Thompson NN; Work Group Members (Datnow B, Dysert PA, Inamdar KV, Kaul KL, Kirkley SA, Mullersman JE, RoseffSD, Stanton CA, Stowell CP, Terrazas E, Zander DS). A consensus curriculum for laboratory management
pathology residents. Am J 2011;1 1
40. Makar RS, Powers A, Stowell CP. Reducing TRALI risk: evidence for and approaches to TRALI mitigation. Transfus Med Reviews. 2012;26:305-20.
41. Cote C, Grabowski E, Stowell CP. Strategies for Blood Product Management and Reducing Transfusions. In: Cote C, Todres I, Ryan F, Goudsouzian N, eds. A Practice of Anesthesia for Infants and Children, 5th ed., W.B. Saunders Co., 2012. pp. 198-220.
42. Dzik WH, Cserti-Gazdewich CM, Stowell CP. Tissue hypoxia results in lactic acidosis. Transfusion. 2013; 53:1168.
43. Stowell, CP, Haas JJ. Transfusion Medicine. In Laposata M, ed. Laboratory Medicine: The Diagnosis of Disease in the Clinical Laboratory. McGraw-Hill, New York, NY. 2014. pp. 291315.
44. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, Stowell CP, Dzik W. Cerebral oxygenation during transfusion for profound anemia. Transfusion. 2014; 54: 282.
45. Cote C, Grabowski E, Stowell CP. Strategies for Blood Product Management and Reducing Transfusions. In: Cote C, Todres I, Ryan F, Goudsouzian N, eds. A Practice of Anesthesia for Infants and Children, 61
h ed., W.B. Saunders Co., 2017. In press.
38
46. Stowell, CP, Bennett-Guerrero E. The Decision to Transfuse: One Size Might Not Fit All. Crit Care Med. 2017. In press.
1. Stowell CP, ed. Informed Consent for Blood Transfusions. 2nd ed. Bethesda: American Association of Blood Banks, 1997.
2. Simon T, Dzik W, Snyder E, Stowell C, Strauss R, eds. Principles of Transfusion Medicine. 3rd ed. Baltimore: Lippincott, Williams and Wilkins, 2002.
3. Stowell CP, Dzik WH, eds. Emerging Technologies in Transfusion Medicine. Bethesda: American Association of Blood Banks, 2003.
4. Stowell CP, Sazama K, eds. Informed Consent in Blood Transfusion and Cellular Therapies: Patients, Donors and Research Subjects. Bethesda: AABB Press, 2007.
5. Simon T, Snyder E, Solheim B, Stowell C, Strauss R, eds. Principles of Transfusion Medicine. 4rd ed. Boston: Blackwell Publishing Inc., 2009.
Case Reports
1. Massachusetts General '-'-"'"'"''-'- two an a woman
splenomegaly. New Engl J Med, 1993;329:1254-6.
2. Stowell CP, Gelfand, J, Shepard J, Kratz A. Case Records of the Massachusetts General Hospital. Case 17-2007: A 25 year-old woman with relapsing fevers and recent onset of dyspnea. New Engl J Med. 2007;356:69-75.
3. Manian FA, Barshak MB, Lowry, KP, Basnet KM, Stowell CP. Case Records ofthe Massachusetts General Hospital. Case: A 71-year-old woman with Mullerian carcinoma, fever, fatigue, and myalgias. New Engl J Med. 2016;375:981-91.
Letters to the Editor
1. Thurer RL, Luban NL, AuBuchon JP, Silver H, McCarthy LJ, Dzik S, Stowell CP, Moore SB, Vamvakas EC, Armstrong W, Kanter MH, Jeter E, Becker J, Higgins M, Galel S, Kleinman S, Marshall CS, Newman R, Ocariz JA, Blackall D, Petz LD, Toy P, Oberman H, Siegel DL, Price TH, Slichter SJ. Universalleukoreduction. Transfusion. 2000;40:751-2.
2. Darabi K, Dzik WH, Stowell CP, Saito Y. Leukoreduction and variant Creutzfeldt-Jakob disease. Transfusion Medicine 2005; 15:1.
39
3. SloanS, Steiner ME, Stowell CP, Assmann SF, Delaney, M, Triulzi D. Transfusion of fresh but not old stored blood reduces infarct size and improves cardiac function after acute myocardial infarction in anemic rats. Crit Care Med 2012;40:2927.
4. Steiner ME, Assmann SF, Stowell CP. More on the age of transfused red cells. N Engl J Med. 2015;16:283-4.
Professional Educational Materials
1. Stowell CP. Blood component therapy II. In: Blood Banking. Eds: Spiegel, DM, Momberger, H, Rhamy, J. American Association of Blood Banks/ Health and Education Resources, Inc., Bethesda, MD, 1994, pp. 35-41. A textbook intended for use by residents in transfusion medicine.
2. Stowell CP. ed. Questions and Answers About Autologous Blood Transfusion. 2nd ed. Bethesda: American Association of Blood Banks, 1998. This collection of questions and answers addressed clinical, technical and regulatory aspects of autologous transfusion. It was was a publication from the Autologous Transfusion Committee of the AABB which I chaired at the time. I wrote a portion of the publication and edited all of the contributions from additional authors. It was distributed nationally.
3. Stowell CP. (7 case studies): Whose my daddy?; The awful alios: managing the patient with multiple alloantibodies; delayed transfusion reation run amok; Emergency
it way; Elective transfusion in a Jehovah's Witness. In: Simon T, Dzik W, Snyder E, Stowell C, Strauss R, eds. Principles of Transfusion Medicine. 3rd ed. Baltimore: Lippincott, Williams and Wilkins: Philadelphia, 2002, pp. 123-4, 135-7,483-5, 644-6, 699-701, 829-30,940-2. Case studies intended for use by residents, fellows and attending level physicians. Several of them have been adapted as 'unknowns' for case conferences with MGH residents.
Stowell CP, Petrides M. Jehovah's Witness Surgery. In: Simon T, Snyder E, Solheim B, Stowell C, Strauss R, eds. Principles of Transfusion Medicine. 4rd ed. Boston: Blackwell Publishing Inc., 2009. One of a set of interactive case studies on CD-ROM intended for use by residents, fellows and attending level physicians. The residents at MGH and fellows in the Harvard fellowship program in transfusion medicine have this textbook and its accompanying CD-ROM.
5. Stowell CP. Informed Consent for Transfusion. AABB Patient Blood Management E-Learning Module, 2015.
Clinical Guidelines
1. Stowell CP, ed. Guidelines for perioperative blood recovery and reinfusion in surgery and trauma. Bethesda: American Association of Blood Banks, 1998. Clinical and technical guidelines developed by the Autologous Transfusion Committee of the AABB.
40
Thesis:
1. Stowell CP. The 2-imino-2-methoxyethyll-thioglycosides: New reagents for attaching carbohydrates to proteins. [dissertation]. Baltimore (MD): The Johns Hopkins University, 1978. 295 p.
